m.achebe
TL2 Moderator · Galway
Contributes reviews on supplier material. Based in Galway.
Joined 5 September 2025 · last posted 3d
70Posts here
1Topics
2Solutions
166Likes received
78Likes given
19Badges
103Days visited
1kPosts read
Recent activity
Full stream-
The anatomy of a question that gets answered within an hour Replied, post #125 · Start Here › How to Ask · 25 Jul 2026 · 17 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
What is genuinely unknown about long-term amylin agonism Replied, post #34 · Compounds › Cagrilintide & amylin analogues · 14 Jul 2026 · 5 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #2 · Compounds › Oral incretins · 13 Jul 2026 · 7 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #41 · Access › Pricing · 10 Jul 2026 · 0 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
Language barriers in accessing a prescription abroad Replied, post #2 · marked as the solution · Access › International · 5 Jul 2026 · 13 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #53 · Analytics › Impurities & related substances · 21 Jun 2026 · 2 likes Coming back to post #51, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #32 · Sourcing › Independent verification · 21 Jun 2026 · 12 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #57 · Analytics › HPLC & UHPLC · 13 Jun 2026 · 0 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #18 · Access › Insurance & coverage · 13 Jun 2026 · 14 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Coming back to: Time to steady state after a dose increase Replied, post #71 · Pharmacology › Pharmacokinetics · 7 Jun 2026 · 18 likes Picking up post #68: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #130 · Practice › Storage & stability · 7 Jun 2026 · 8 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Designing a personal experiment that could change your mind — one year on Replied, post #55 · Research Methods › N-of-1 designs · 3 Jun 2026 · 4 likes This follows post #52 rather than contradicting it. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect…